Malignancy-associated hemophagocytic lymphohistiocytosis in adults: A retrospective population-based analysis from a single center

Leukemia and Lymphoma

Volumn 52, Issue 4, 2011, Pages 613-619

  MacHaczka, MacIej ^a,b   Vaktnäs, Johan ^b   Klimkowska, Monika ^a   Hägglund, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b VARBERG HOSPITAL   (Sweden)

Author keywords

Hemophagocytic lymphohistiocytosis; hemophagocytic syndrome; hemophagocytosis; malignancy; malignancy associated

Indexed keywords

ALEMTUZUMAB; BETAMETHASONE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953220496     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.551153     Document Type: Article

References (27)

1. Henter J-I, Elinder G, Söder O, Ost A Incidence in Sweden and clinical features of familial hemophagocytic lymphohis-tiocytosis. Acta Paediatr Scand 1991;80:428-435.
2. Henter J-I, Arico M, Elinder G, Imashuku S, Janka G. Familial hemophagocytic lymphohistiocytosis (primary HLH). Hematol Oncol Clin North Am 1998;12:417-433. (Pubitemid 28175890)
3. Ost A, Nilsson-Ardnor S, Henter J-I. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histo-pathology 1998;32:310-316. (Pubitemid 28186588)
4. Janka G, Imashuku S, Elinder G, Schneider M, Henter J-I. Infection-and malignancy-associated hemophagocytic syn-dromes. Hematol Oncol Clin North Am 1998;12:435-444.
5. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr 2009;221:278-285.
6. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009:127-131.
7. Nagafuji K, Nonami A, Kumano T, et al. Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica 2007;92:978-981. (Pubitemid 350144246)
8. Meeths M, Entesarian M, Al-Herz W, et al. Spectrum of clinical presentations in familial hemophagocytic lymphohis-tiocytosis type 5 patients with mutations in STXBP2. Blood 2010;116:2635-2643.
9. Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic auto-immune disease: analysis of 30 cases. Rheumatology 2008;47: 1686-1691.
10. Gupta AA, Tyrrell P, Valani R, Benseler S, Abdelhaleem M, Weitzman S. Experience with hemophagocytic lymphohistio-cytosis/macrophage activation syndrome at a single institution. J Pediatr Hematol Oncol 2009;31:81-84.
11. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14. (Pubitemid 38021618)
12. Henter J-I, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-2922.
13. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988;67:369-388. (Pubitemid 19003323)
14. Hasselblom S, Linde A, Ridell B. Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome. J Intern Med 2004;255:289-295. (Pubitemid 38241374)
15. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86:58-65. (Pubitemid 47204491)
16. Han A-R, Lee HR, Park B-B, et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol 2007;86:493-498. (Pubitemid 46863886)
17. Lackner H, Urban C, Sovinz P, Benesch M, Moser A, Schwinger W. Hemophagocytic lymphohistiocytosis as severe adverse event ofantineoplastic treatment in children. Haema-tologica 2008;93:291-294. (Pubitemid 351397720)
18. Tong H, Ren Y, Liu H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and with-out hemophagocytic syndrome. Leuk Lymphoma 2008;49: 81-87. (Pubitemid 351146886)
19. Machaczka M, Vaktnäs J, Klimkowska M, Nahi H, Hägglund H. Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma. Med Oncol 2010:Apr 1. [Epub ahead of print].
20. Henter J-I, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistio-cytosis. Pediatr Blood Cancer 2007;48:124-131. (Pubitemid 44958267)
21. Henter J-I, Samuelsson-Horne AC, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immu-notherapy and bone marrow transplantation. Blood 2002;100: 2367-2373.
22. Shabbir M, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol 2010 Aug 30. [Epub ahead ofprint].
23. OstronoffM, OstronoffF, Coutinho M, et al. Hemophago-cytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma: successful treatment with high-dose intravenous immunoglobulin. Bone Marrow Transplant 2006;37:797-798.
24. Sreedharan A, Bowyer S, Wallace CA, et al. Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 2006;37:629-634.
25. Abdelkefi A, Jamil WB, Torjman L, et al. Hemophagocytic syndrome after hematopoietic stem cell transplantation: a pro-spective observational study. IntJHematol 2009;89:368-373.
26. Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocy-tosis. Br J Haematol 2005;129:622-630. (Pubitemid 40825824)
27. Marsh RA, Vaughn G, Kim M-O, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic he-matopoietic cell transplantation. Blood 2010;116:5824-5831.